Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;23(3):258-69.
doi: 10.1055/s-2006-948765.

Catheter-directed thrombolysis for acute limb ischemia

Harry L Morrison  1
Affiliations

Catheter-directed thrombolysis for acute limb ischemia

Harry L Morrison. Semin Intervent Radiol. 2006 Sep.

Abstract

Acute limb ischemia is a potentially life-threatening clinical event. Thrombosis in situ, bypass graft thrombosis, and embolic occlusion are the three major precipitating events leading to acute limb ischemia. Management of acute ischemia depends on the clinical status of the affected limb and patient comorbidities. Catheter-directed thrombolysis (CDT) is the treatment of choice for patients with relatively mild acute limb ischemia (Rutherford categories I and IIa) with no contraindications to thrombolytic therapy. Patients with severe acute limb ischemia (Rutherford category IIb) need emergent revascularization. CDT should be considered, nonetheless, if the relative risks compared with primary operation are favorable. CDT is a life- and limb-saving treatment for many patients despite limitations of efficacy and associated complications. This article is a review of the etiology of acute arterial occlusion; clinical triage of patients presenting with acute limb ischemia; catheter guide wire techniques, pharmacological agents, and devices in current use for CDT; as well as the outcomes of CDT.

Keywords: Thrombolysis; acute limb ischemia; anticoagulation; plasminogen activator.

PubMed Disclaimer

Figures

Figure 1
Figure 1
An elderly woman with history of atrial fibrillation presented with painful and cold left hand and absent brachial and wrist pulses. Initial angiography from a left CFA approach showed tandem emboli in the (A) proximal and (B) distal left brachial artery. Following 36-hour infusion of alteplase at 1.0 mg/h divided between a 5F multi-side hole infusion catheter and a 3F microcatheter, with heparin at 300 U/h, there was no residual embolus in the (C) left upper arm or (D) the left forearm.
Figure 2
Figure 2
An 80-year-old man with history of hypertension presented with a painful and cold left foot and absent popliteal and pedal pulses. (A) Initial angiography from a right CFA approach showed acute occlusion of the left superficial femoral artery. (B) After placing a 6F up-and-over sheath, a 5F multi-side hole infusion catheter was placed with the tip in the distal left popliteal artery. Alteplase (1.0 mg/h via the catheter) and heparin (200 U/h via the sheath) infusions were initiated. (C) Follow-up angiography the next day showed no residual thrombus, a high-grade stenosis at the origin of the left peroneal artery, and proximal occlusion of the left posterior and anterior tibial arteries.
Figure 3
Figure 3
A 67-year-old man 1 week after left popliteal artery reconstruction using autologous vein bypass graft presented with acute ischemia in the left foot and calf. The patient was referred for CDT because of risks involved in reoperation and despite warning of significant bleeding risks with CDT therapy. (A) A 5F multi-side hole catheter was placed within the graft and alteplase (0.5 mg/h via the catheter) and heparin (200 U/h via an up-and-over sheath) were initiated. (B) Follow-up angiography the next day showed a large pseudoaneurysm at the proximal anastamosis and persistent occlusion of the distal anastamosis. The patient was then taken to the operating room emergently for hematoma evacuation and graft repair.
See this image and copyright information in PMC

References

    1. Kasirajan K, Ouriel K. Management of acute lower extremity ischemia: treatment strategies and outcome. Curr Interv Cardiol Rep. 2000;2:119–129. - PubMed
    1. Camerta A, White J V. In: Camerta A, editor. Thrombolytic Therapy for Peripheral Vascular Disease. Philadelphia: Lippincott-Ravenm; 1995. Overview of catheter directed thrombolytic therapy for arterial and graft occlusion. pp. 249–252.
    1. Dotter C T, Rosch J, Seaman A J. Selective clot lysis with low-dose streptokinase. Radiology. 1974;111:31–37. - PubMed
    1. Kasirajan K, Haskal Z J, Ouriel K. The use of mechanical thrombectomy devices in the management of acute peripheral arterial occlusive disease. J Vasc Interv Radiol. 2001;12:405–411. - PubMed
    1. Hirsch A T, Haskal Z J, Hertzer N R, et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine and Biology, and the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease). American College of Cardiology Web Site. Available at: http://www.acc.orglclinicaJ/guidelines/padlindex.pdf. Accessed March 16, 2006. Available at: http://www.acc.orglclinicaJ/guidelines/padlindex.pdf - PubMed